In conclusion, CD14+ cells from patients with early-stage HCC exhibited poor PD-L, IL-12, and IL-10 expression and were negative for CCL17, CCL1, and CXCL13 (considered a quiescent Mφ phenotype). The gene discussed is CD14; the disease is hepatocellular carcinoma.